-
Stable Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-10-01
The reference study develops a stable isotope-diluted UHPLC–ESI–MS/MS workflow for sensitive, quantitative analysis of methylated purine nucleosides in cellular samples. Its combination of ammonium bicarbonate-enhanced ionization, chromatographic isomer separation, and extraction cleanup improves measurement reliability for RNA modification research, metabolomics, and biomarker discovery.
-
Rucaparib (AG-014699) DNA Repair Workflows
2026-10-01
Rucaparib (AG-014699) enables controlled studies of PARP1 inhibition, persistent DNA breaks, and radiation response across repair-deficient cancer models. This practical guide connects radiosensitization assays with emerging SmD2–BRCA1/FANC splicing biology in hepatocellular carcinoma.
-
Dextromethorphan Hydrobromide: Assay Architecture
2026-09-30
Dextromethorphan hydrobromide is a versatile NMDA receptor antagonist for mechanistic neuroprotection research. This guide develops an assay-architecture framework that separates receptor effects, ion-channel modulation, and translational evidence while placing the compound in proper scientific context.
-
Busulfan Workflows for Senescence and Germ-Cell Models
2026-09-30
Busulfan enables two complementary experimental designs: controlled senescence induction in WI38 fibroblasts and targeted germ-cell injury in mouse models. This workflow guide connects DNA crosslinking, MAPK signaling, and dual-recombinase lineage tracing while emphasizing dosing discipline, assay controls, and interpretation limits.
-
Oteseconazole (VT-1161): CYP51 Antifungal Guide
2026-09-29
Oteseconazole, also called VT-1161, is a selective tetrazole CYP51 inhibitor with potent in vitro activity against multiple Candida species. Its strongest translational role is prevention of recurrent vulvovaginal candidiasis, while laboratory data support research on Candida albicans and fluconazole-resistant Candida.
-
NP-40 Lysis Buffer: Reliable Native Protein Workflows
2026-09-29
Learn how NP-40 Lysis Buffer supports reproducible protein recovery for viability, proliferation, cytotoxicity, and neuroimmune assays. This scenario-based guide explains when SKU K1127 is appropriate, how to optimize it, and how to evaluate formulation quality, workflow cost, and vendor reliability.
-
Baicalein and Selective Pathway Modulation
2026-09-28
Baicalein is a 12-lipoxygenase pathway inhibitor used to investigate arachidonic acid metabolism, inflammation, and cancer-cell responses. This article connects its pathway-focused research applications to a neurotoxicity study that illustrates why protective effects in one cell type cannot be assumed to preserve drug activity in another.
-
XPO1 Inhibition Limits Colorectal Tumorigenesis
2026-09-27
A 2024 bioRxiv preprint reports that the XPO1 inhibitor Eltanexor reduces COX-2 expression by modulating Wnt/β-catenin signaling and lowers tumor burden in Apcmin/+ mice. The findings connect nuclear export to a key colorectal cancer pathway and support further evaluation of XPO1 inhibition as a chemoprevention strategy, while remaining preclinical.
-
ICI 118,551 Hydrochloride in Stroke Research
2026-09-26
Use ICI 118,551 hydrochloride as a hypothesis-testing pharmacological probe alongside CKLF1-focused neutrophil assays—not as an established stroke treatment or a substitute for esculetin. The workflow below separates the reference study’s findings from proposed assay conditions and shows how to test for independent or interacting effects.
-
Reading Senescence in Cisplatin-Resistant HNSCC
2026-09-26
SLC25A1 links metabolic regulation to senescence-associated cisplatin resistance in HNSCC. This article explains how translational teams can use lysosomal β-galactosidase staining as a carefully interpreted control readout—not a stand-alone measure of senescence—and build stronger validation workflows.
-
Dual Recombinase Tracing Finds No Mouse Neo-oogenesis
2026-09-25
Xie, Zhou, and Zheng used complementary Cre-loxP and Dre-rox lineage tracing to test whether ovarian cells generate new oocytes after birth. They detected no traced growing oocytes or mature eggs under physiological conditions or after busulfan-induced ovarian injury, strengthening evidence against postnatal neo-oogenesis in mice.
-
SB 431542 for Mesodermal Organoid Workflows
2026-09-25
Use SB 431542 to test how ALK5-linked TGF-β signals shape cell identity and organization in mesodermal organoid models. This guide connects a recent limb-like organoid study to practical perturbation workflows, with controls and troubleshooting that help separate pathway effects from changes in viability or lineage composition.
-
Bovine Insulin for More Reproducible Cell Assays
2026-09-24
This scenario-based guide explains how Bovine Insulin (SKU A5981) can be handled and evaluated in cell viability, proliferation, and cytotoxicity workflows. It connects product specifications with practical controls while distinguishing product facts from mechanistic evidence and assay-specific recommendations.
-
Esculetin Limits Neutrophil Infiltration After Stroke
2026-09-24
In a mouse photothrombotic stroke model, esculetin reduced infarct burden and improved behavioral and functional-imaging outcomes, with evidence implicating CKLF1–CCR5 signaling and neutrophil recruitment. The findings connect an anti-inflammatory mechanism to post-stroke recovery, while remaining preclinical and requiring validation in other stroke models and in humans.
-
Nicotine Signaling and CKD Progression in Smokers
2026-09-23
Jain and Jaimes synthesize clinical and experimental evidence that nicotine may help connect cigarette smoking with chronic kidney disease progression through non-neuronal nicotinic acetylcholine receptors, reactive oxygen species, hemodynamic changes, and profibrotic signaling. The review’s main practical contribution is a mechanistic framework for separating nicotine-related effects from the broader toxicity of tobacco smoke and for designing kidney injury studies with appropriate receptor, oxidative-stress, and fibrosis endpoints.